☆ 4.6 Editorial Material

microRNA-17∼92 is a powerful cancer driver and a therapeutic target

CELL CYCLE (2014)

Get Full Text
Add to Collection

Journal

CELL CYCLE
Volume 13, Issue 4, Pages 495-496

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.27784

Keywords

therapeutics; lymphoma; cancer; MicroRNA; NF kappa B; PI3K; miR-17~92

Categories

Cell Biology

Funding

  1. NIAID NIH HHS [R01 AI087634, R01 AI121155] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.